Vision for 2025 and Strengthening the Earnings Base through Stage I and Stage II
First written in FY2020. 3 of 6 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026ReframedAnnual report
「The Group will pursue the 2028 Medium-Term Management Plan, the business-domain expansion stage, toward the desired state for fiscal 2030 defined in NOF VISION 2030, whose final year is fiscal 2030.」
The framework was updated from the Stage I and Stage II plan structure targeting 2025 to NOF VISION 2030, which targets the desired state for fiscal 2030, and the business-domain expansion stage under the 2028 Medium-Term Management Plan. - FY2026-H1RestatedAnnual report
「Under the three-year 2025 Medium-Term Management Plan, which ends in fiscal 2025, the Group has adopted “Execution and Leaps Forward” as its basic policy and is addressing the priorities of expanding its business by responding to market changes, accelerating the development of new products and technologies, improving productivity, pursuing safety and security, and promoting CSR. At the same time, it has worked to develop new markets and expand sales, reduce production costs, and build on its management efforts toward sustainable growth.」
As the final year of the 2025 Medium-Term Management Plan, the Company continues to pursue the earnings expansion framework corresponding to Stage II. - FY2024-Q2RestatedAnnual report
「Under the three-year 2025 Medium-Term Management Plan, which begins in the current fiscal year, the Group has adopted “Execution and Leaps Forward” as its basic policy and is addressing the priorities of expanding its business by responding to market changes, accelerating the development of new products and technologies, improving productivity, pursuing safety and security, and promoting CSR」
As the first year of the 2025 Medium-Term Management Plan, which corresponds to Stage II of NOF VISION 2025, the Company continues to pursue its basic policy and 5 priority issues. - FY2024-Q1AdvancedAnnual report
「Under the three-year 2025 Mid-Term Management Plan, whose first year is the current fiscal year, we adopted "Execution and Advancement" as the basic policy and addressed the following issues: expanding our business by responding to market changes, accelerating the development of new products and technologies, improving productivity, pursuing safety and security, and promoting CSR,」
The 2025 Medium-Term Management Plan, corresponding to Stage II toward the desired state for 2025, began with the current fiscal year as its first year. Its basic policy and 5 priority issues have been specified. - FY2021RestatedAnnual report
「To achieve the next stage of growth, the Group formulated “NOF VISION 2025,” beginning in 2020. The first 3 years, covered by the “2022 Medium-Term Management Plan,” constitute Stage I, the foundation-strengthening stage, while the latter 3 years constitute Stage II, the earnings expansion stage. The Group is advancing initiatives including proactive investment in growth areas and strengthening earnings power.」
The Company reaffirmed NOF VISION 2025 and its 2-stage plan comprising Stage I and Stage II. - FY2020First statedAnnual report
「The Group defined its desired state for 2025 as “a corporate group that creates new value through the power of chemistry in the 3 fields of ‘life and healthcare,’ ‘electronics and information,’ and ‘environment and energy’ to realize a prosperous and sustainable society.” During the 6 years through 2025, the first 3 years, covered by the 2022 Medium-Term Management Plan, are designated as Stage I, the foundation-strengthening stage. The Group will actively invest in growth areas while strengthening its earnings base. The latter 3 years, covered by the 2025 Medium-Term Management Plan, are designated as Stage II, the earnings expansion stage. The Group will expand its business performance and sustain growth.」
The Company introduced a 2-stage plan covering the 6 years through 2025, positioning the first half as the foundation-strengthening stage and the second half as the earnings expansion stage.